دورية أكاديمية

Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma

التفاصيل البيبلوغرافية
العنوان: Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma
المؤلفون: Evans, Thomas R. Jeffry, Kudo, Masatoshi, Finn, Richard S., Han, Kwang-Hyub, Cheng, Ann-Lii, Ikeda, Masafumi, Kraljevic, Silvija, Ren, Min, Dutcus, Corina E., Piscaglia, Fabio, Sung, Max W.
المصدر: British Journal of Cancer ; volume 121, issue 7, page 625-625 ; ISSN 0007-0920 1532-1827
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2019
مصطلحات موضوعية: Cancer Research, Oncology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1038/s41416-019-0534-2
الإتاحة: https://doi.org/10.1038/s41416-019-0534-2Test
http://www.nature.com/articles/s41416-019-0534-2.pdfTest
http://www.nature.com/articles/s41416-019-0534-2Test
حقوق: https://creativecommons.org/licenses/by/4.0Test ; https://creativecommons.org/licenses/by/4.0Test
رقم الانضمام: edsbas.DC44DB1A
قاعدة البيانات: BASE